Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03892759 · ClinicalTrials.gov registry record · NA

Osteopathic Manipulative Treatment for Back Pain

A NA study, sponsored by Pacific Northwest University of Health Sciences.

Completed
Registry status
NA
Development phase
31
Enrollment target

NCT03892759: Completed NA study, sponsored by Pacific Northwest University of Health Sciences.

NCT03892759 is a NA study that has completed, run by Pacific Northwest University of Health Sciences. The registered enrollment target is 31 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03892759, a NA study, has completed, sponsored by Pacific Northwest University of Health Sciences.

COMPLETED
Registry status
NA
Development phase
31 participants
Enrollment target

Study Summary

This study will investigate if Osteopathic Manipulative Treatment (OMT) is beneficial for patients presenting with back pain.

Primary Outcome

Functional Status as measured by Roland-Morris Disability Questionnaire. Question responses are totaled for a score of 0 to 24 with higher number indicating a worse outcome or greater level of disability.

Interventions

  • OTHER Osteopathic Manipulative Therapy

Trial Details

FieldValue
Enrollment Target 31 participants
Start Date 2019-04-01
Est. Completion 2022-03-04
Phase NA

What the finished NCT03892759 record still lists

NCT03892759 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 31 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which Osteopathic Manipulative Therapy is the first listed.

NCT03892759 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03892759 about?

NCT03892759 is a clinical study titled "Osteopathic Manipulative Treatment for Back Pain". This study will investigate if Osteopathic Manipulative Treatment (OMT) is beneficial for patients presenting with back pain.

What is the current status of trial NCT03892759?

This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2019-04-01. Estimated completion is 2022-03-04.

What interventions are being tested in trial NCT03892759?

The interventions under investigation include: Osteopathic Manipulative Therapy (OTHER).

Who is sponsoring clinical trial NCT03892759?

This trial is sponsored by Pacific Northwest University of Health Sciences, which has 10 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03892759's enrollment target sits among peer trials

31 1592nd of 2000 higher than 408 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02932618 · 31 participants · Phase 3

    A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)

  • NCT03482297 · 31 participants · Phase 1

    Automated Abdominal Binder for Orthostatic Hypotension

  • NCT04016389 · 31 participants · NA

    FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery

  • NCT04211675 · 31 participants · Phase 1

    NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03892759, the US trial registry maintained by the National Library of Medicine. NCT03892759 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.